3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
7
Colonic Neoplasms
3
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Peritoneal Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Neoplasm Metastasis
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Krukenberg Tumor
1
Hyperthermia
1
Eye Neoplasms
1
Endometrial Neoplasms
1
Complex Ovarian Cyst
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Interventions
Paclitaxel
114
Carboplatin
114
Cisplatin
45
Topotecan
43
Gemcitabine
31
Cyclophosphamide
31
Docetaxel
28
liposomal doxorubicin
27
Bevacizumab
27
Filgrastim
20
pembrolizumab
19
Peripheral Blood Stem Cell Transplantation
18
Taxes
15
Drug Therapy
15
sargramostim
12
Hyperthermic Intraperitoneal Chemotherapy
12
olaparib
11
Chemotherapy, Adjuvant
10
Surgical Procedures, Operative
9
Etoposide
9
oregovomab
8
mirvetuximab soravtansine
8
Nivolumab
8
Amifostine
8
Therapeutics
7
Melphalan
7
Erlotinib Hydrochloride
7
rucaparib
6
aldesleukin
6
Oxaliplatin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Ovarian Epithelial
×
Laparotomy
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts